Sort
326,823 grants matching “clinical trial”
Global Brain Health Predictors of Post-Stroke Sensorimotor Recovery using AI-Enhanced Clinical MRIs
$2,942,690Sook-Lei Liew · University Of Southern California · RF1 · FY2025 · NS
Hyperthermia and Perfusion Effects in Cancer Therapy
$2,942,626Mark Wesley Dewhirst · Duke University · P01 · FY2009 · CA
Cardiovascular CT Clinical Research
$2,942,520Marcus Chen · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Cervical cancer and human papillomavirus (HPV) infection
$2,941,829Mark Schiffman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Carbon Monoxide: Novel Opportunities for Therapy
$2,941,791Augustine M Choi · Brigham And Women'S Hospital · P01 · FY2011 · HL
Characterization of the Pathogenesis of Lymphangioleiomyomatosis (LAM)
$2,941,694Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Collective Intelligence, Knowledge Infrastructure, & High Performance Computing
$2,941,656Calvin A Johnson · Center For Information Technology · ZIH · FY2009 · CT
Vanderbilt HIV Clinical Trials Unit
$2,941,559David W Haas · Vanderbilt University Medical Center · UM1 · FY2019 · AI
Penn Center for AIDS Research
$2,940,869Ronald G Collman · University Of Pennsylvania · P30 · FY2024 · AI
ACOSOG Competing Renewal
$2,940,780Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2012 · CA
ACOSOG Competing Renewal
$2,940,780David M. Ota · Duke University · U10 · FY2011 · CA
ACOSOG Competing Renewal
$2,940,780Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2013 · CA
Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.
$2,940,354Theodore S Hong · Massachusetts General Hospital · P01 · FY2021 · CA
Genetic Studies of Alzheimer Disease in Koreans
$2,939,748Lindsay A. Farrer · Boston University Medical Campus · U01 · FY2019 · AG
Alzheimer's Disease Research Center
$2,939,745Thomas J. Grabowski · University Of Washington · P50 · FY2016 · AG
Lead Optimization and Preclinical Development of Human Nicotine-Specific mAbs
$2,939,717Matthew W Kalnik · Antidote Therapeutics, Inc. · R01 · FY2016 · DA
ID-CTP Clinical Core
$2,939,106Sung-Yun Pai · Division Of Basic Sciences - Nci · ZID · FY2024 · CA
Wisconsin NCI Community Oncology Research Program (WiNCORP)
$2,938,983Adedayo A Onitilo · Marshfield Clinic Research Foundation · UG1 · FY2020 · CA
Growth factors, neuroinflammation, exercise, and brain integrity
$2,938,975Paul M Thompson · University Of Southern California · RF1 · FY2014 · AG
PEDIATRIC PRECLINICAL TESTING PROGRAM
$2,938,868Peter J Houghton · Research Inst Nationwide Children'S Hosp · N01 · FY2010 · CA
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$2,938,698Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2016 · AI
Natives Engaged in Alzheimer's Research
$2,938,224Dedra S Buchwald · Washington State University · P01 · FY2022 · AG
Hyperthermia and Perfusion Effects in Cancer Therapy
$2,938,079Duke University · P01 · FY2005 · CA
Development of a Potent and Highly Selective NaV1.7 Inhibitor for the Treatment of Acute Pain with the Goal of Reducing Opioid Use and Preventing Opioid Use Disorders
$2,937,963John Cureton Hunter · Siteone Therapeutics, Inc. · UG3 · FY2019 · DA
NIA AD/ADRD Health Care Systems Research Collaboratory
$2,937,738Vincent Mor · Brown University · U54 · FY2021 · AG